Moreover, multiple biomarkers have been employed in the assessment of angiogenesis [CD 105, CD 34 and Vascular endothelial growth factor (VEGF)] in odontogenic tumors, and various laboratory techniques have been used (Seifi et al., 2011, El‚Labban and Aghabeigi, 1990, Rubini et al., 2011). This evidence concerns the gene VEGFA and odontogenic neoplasm.